Onconova Therapeutics (ONTX) News Today → FW: 234x Gain (From Weiss Ratings) (Ad) Free ONTX Stock Alerts Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineStockNews.com Initiates Coverage on Onconova Therapeutics (NASDAQ:ONTX)americanbankingnews.com - May 2 at 5:14 AMOnconova Therapeutics (NASDAQ:ONTX) Now Covered by StockNews.comamericanbankingnews.com - April 24 at 2:22 AMOnconova and Trawsfynydd merge to form Traws Pharmauk.investing.com - April 4 at 6:50 PMTraws Pharma Full Year 2023 Earnings: Beats Expectationsfinance.yahoo.com - April 4 at 6:50 PMNewtown’s Onconova Therapeutics Secures $14 Million and New CEO in Merger with Trawsfynyddmsn.com - April 3 at 5:47 PMOnconova Acquires Trawsfynydd To Form Traws Pharmamarkets.businessinsider.com - April 2 at 10:00 AMTraws Pharma Announces New Employee Inducement Grantsglobenewswire.com - April 2 at 7:15 AMOnconova to Unveil New Rigosertib Study Results at Cancer Research Meetingmsn.com - March 12 at 8:48 AMAnalysts Offer Insights on Healthcare Companies: Onconova Therapeutics (ONTX) and Biogen (BIIB)markets.businessinsider.com - March 11 at 1:17 PMOnconova Therapeutics’ Rigosertib Poster Selected for AACR 2024finance.yahoo.com - March 8 at 9:56 AMOnconova Therapeutics' Rigosertib Poster Selected for AACR 2024globenewswire.com - March 8 at 8:00 AMOnconova Therapeutics Inc (ONTX)investing.com - February 13 at 12:22 AMOnconova Therapeutics, Inc. (ONTX)finance.yahoo.com - January 23 at 10:41 PMOnconova Therapeutics Stock (NASDAQ:ONTX) Dividends: History, Yield and Datesbenzinga.com - December 21 at 11:07 PMOnconova stock falls 10% on preclinical data for lymphoma drugmsn.com - December 12 at 4:02 PMOnconova Therapeutics’ Narazaciclib ASH Poster Highlights Activity in Treatment Resistant Mantle Cell Lymphomafinance.yahoo.com - December 12 at 9:55 AMOnconova Therapeutics’ Preclinical Narazaciclib Data at SABCS Highlights Differentiated Anti-Tumor Activity v. Other CDK4/6i’sfinance.yahoo.com - December 8 at 6:47 PMOnconova Therapeutics to Present at NobleCon19, Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conferencefinance.yahoo.com - November 28 at 10:06 AMOnconova Therapeutics, Inc. (NASDAQ:ONTX) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 16 at 12:48 PMOnconova Therapeutics, Inc.: Onconova Therapeutics Reports Corporate Update and Announces Third Quarter 2023 Financial Resultsfinanznachrichten.de - November 16 at 1:30 AMOnconova Therapeutics Reports Corporate Update and Announces Third Quarter 2023 Financial Resultsfinance.yahoo.com - November 14 at 6:28 PMOnconova Therapeutics to Provide Corporate Update and Announce Third Quarter 2023 Financial Results on November 14, 2023finance.yahoo.com - November 7 at 5:22 PMOnconova Therapeutics' ASH Poster To Focus on Narazaciclib in MCLbenzinga.com - November 2 at 7:56 PMOnconova Therapeutics’ ASH Poster To Focus on Narazaciclib in MCLfinance.yahoo.com - November 2 at 2:55 PMPromising Developments in Onconova Therapeutics’ Drug Narazaciclib Bolster Buy Rating: An Analysismarkets.businessinsider.com - October 19 at 3:29 PMPromising Preclinical Narazaciclib Data Presented at MCL Meetingfinance.yahoo.com - October 19 at 10:29 AMOnconova Therapeutics Shares Rise 12% On Skin Cancer Treatment Datamarketwatch.com - October 12 at 5:04 PMEncouraging Rigosertib Data Presented at EADV as Late Breakerfinance.yahoo.com - October 12 at 12:04 PMOnconova Therapeutics to Present a Late-Breaking Abstract on Rigosertib at the 2023 EADV Congressfinance.yahoo.com - September 28 at 10:16 AMOnconova Therapeutics to Participate at the H.C. Wainwright 25th Annual Global Investment Conferencefinance.yahoo.com - September 6 at 8:54 AMH.C. Wainwright Sticks to Their Buy Rating for Onconova Therapeutics (ONTX)markets.businessinsider.com - August 11 at 5:58 PMQ2 2023 Onconova Therapeutics Inc Earnings Callfinance.yahoo.com - August 11 at 5:58 PMOnconova Therapeutics Reports Corporate Update and Announces Second Quarter 2023 Financial Resultsfinance.yahoo.com - August 10 at 7:20 PMOnconova Therapeutics to Provide Corporate Update and Announce Second Quarter 2023 Financial Results on August 10, 2023finance.yahoo.com - August 3 at 6:07 PMHere's Why We're Watching Onconova Therapeutics' (NASDAQ:ONTX) Cash Burn Situationfinance.yahoo.com - July 17 at 9:19 AMOnconova Therapeutics Presents Preclinical Data on Narazaciclib at the 17th International Conference on Malignant Lymphomafinance.yahoo.com - June 14 at 10:07 AMHC Wainwright & Co. Reiterates Onconova Therapeutics (ONTX) Prior Recommendationmsn.com - June 7 at 3:30 AMOnconova Therapeutics (ONTX) Receives a Buy from H.C. Wainwrightmarkets.businessinsider.com - June 6 at 7:26 AMOnconova Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology Annual Meetingfinance.yahoo.com - June 5 at 9:20 AMOnconova Therapeutics Announces Dosing of First Participant in Investigator-Sponsored Phase 2 Trial of Rigosertib Plus Pembrolizumab in Metastatic Melanoma Patients Refractory to Immune Checkpoint Blockadefinance.yahoo.com - May 25 at 8:28 AM8-K: Onconova Therapeutics, Inc.marketwatch.com - May 17 at 3:52 PMHC Wainwright & Co. Reiterates Onconova Therapeutics (ONTX) Buy Recommendationmsn.com - May 16 at 10:44 PMOnconova Therapeutics (ONTX) Gets a Buy from Noble Financialmarkets.businessinsider.com - May 16 at 12:42 PMOnconova Therapeutics, Inc.: Onconova Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updatefinanznachrichten.de - May 16 at 7:42 AMAnalysts Offer Insights on Healthcare Companies: Onconova Therapeutics (ONTX), Cara Therapeutics (CARA) and Minerva Neurosciences (NERV)markets.businessinsider.com - May 16 at 7:42 AMQ1 2023 Onconova Therapeutics Inc Earnings Callfinance.yahoo.com - May 16 at 7:42 AMOnconova Therapeutics: Q1 Earnings Insightsmsn.com - May 15 at 9:41 PMOnconova Therapeutics, Inc. (ONTX) Reports Q1 Loss, Misses Revenue Estimatesfinance.yahoo.com - May 15 at 9:41 PMOnconova Therapeutics (ONTX) Earnings Dates & Reportsinvesting.com - May 15 at 4:41 PMOnconova Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updatefinance.yahoo.com - May 15 at 4:41 PM Get Onconova Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ONTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Never use this word on your phone (FBI could be watching) (Ad)This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions... Watch my unredacted video about what I think is coming next right here ONTX Media Mentions By Week ONTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ONTX News Sentiment▼0.000.43▲Average Medical News Sentiment ONTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ONTX Articles This Week▼11▲ONTX Articles Average Week Get Onconova Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ONTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: INDP News VINC News RNXT News TXMD News ADXN News LSTA News APM News BIVI News MEIP News SYBX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ONTX) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldUrgent Nvidia WarningAltimetryAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldGold ManiaStansberry ResearchThe Gold Grab of the CenturyColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Onconova Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.